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Abstract: A robust two-enzyme system composed of an immobilized ketoreductase (KRED1-Pglu) and a glucose 
dehydrogenase (BmGDH) was developed via immobilization on aldehyde agarose for the stereoselective reduction of different 
ketones. The immobilized ketoreductase/glucose dehydrogenase system was continuously used in a flow reactor for weeks, 
even in the presence of concentrations of DMSO up to 20%. 
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1. Introduction 
Biocatalytic processes can be improved with the use of different and complementary strategies, including protein or metabolic 
engineering and immobilization techniques [1]. Besides, biocatalysis in flow chemistry reactors, where rates and 
productivities can be largely enhanced, seems a logical option [2]. Flow-based applications have potential advantages, such 
as: increased mixing efficiency, controlled scaling factors, improved safety ratings, in-line control and product recovery, easy 
set-up of cascade reactions, and continuous processing capabilities [3-5].  
Flow-based biocatalysis has recently attracted interest for screening, optimizing or setting up preparative biotransformations 
[6, 7]. Biotransformations such as hydrolysis and formation of esters [8-12], formation of C-C bonds using transketolases [13], 
preparation of monosaccharides [14] and oligosaccharides [15], synthesis of nucleosides [16], interconversion of carbonyls 
and amines using transaminases [17, 18], and peptide condensation [19] have been reported in the last few years. 
Stereoselective enzymatic carbonyl reduction with immobilized systems has been poorly investigated [20-23] and, to our 
knowledge, only one example has been reported using an immobilized ketoreductase in a plug flow reactor [24]. Here we 
report the use of a mixed bed system composed of immobilized ketoreductase from Pichia glucozyma (KRED1-Pglu) [25, 
26] and a glucose dehydrogenase from Bacillus megaterium (BmGDH) [27] for the stereoselective reduction of ketones in a 
flow reactor. 
 
2. Experimental 
 
2.1. General procedure for batch biotransformations 
Reactions were carried in 2 mL volume of 50 mM Tris HCl buffer pH 8.0 containing NADP+ (0.1 mM), substrate (0.5 g/L), 
glucose (4 eq × eq of substrate) at 30 °C. The reaction was started by the addition of KRED1-Pglu and BmGDH, maintained 
under orbital shaking (180 rpm), and was monitored by HPLC. 
 
2.2. General procedure for flow biotransformations 
Solutions of the substrates at different concentrations were prepared in Tris HCl buffer pH 8.0 (50 mM) with DMSO (variable 
percentages depending on the substrate, for details see Table 2), 0.1 mM NADP+ and glucose (4 eq × eq of substrate). An 
Omnifit glass column (6.6 mm i.d. x 100 mm) was packed with pre-mixed KRED1-Pglu (540 mg) and BmGDH (540 mg), in 
order to obtain a KRED1-Pglu/BmGDH ratio of 1/25. The volume of the reactor was 0.90 mL. The packed column was pre-
washed by flowing through it a solution of Tris HCl buffer pH 8.0 (0.050 mL/min for 15 minutes) followed by a solution of 
Tris HCl buffer pH 8.0 with DMSO (0.050 mL/min for 15 minutes). Then, the substrate solution was pumped through the 
column maintained at 30 °C. The exiting solution was collected and analyzed at different times. 
See Supplementary Materials for other experimental details.  
Results and Discussion 
Ketoreductase from Pichia glucozyma (KRED1-Pglu) and glucose dehydrogenase from Bacillus megaterium (BmGDH) were 
prepared as previously reported [26, 27] (see Supplementary Materials for details). The first support taken into account was 
the commercially available epoxy-activated Relizyme 403/S. Although KRED1-Pglu was completely bound to the support, 
the resulting biocatalyst was poorly active (4% of expressed activity). Moreover, on the same support only 2% of the offered 
BmGDH was bound to the matrix. Aldehyde activated agarose, a support suitable for the immobilization/stabilization of 
several enzymes [28, 29], including ketoreductases, was alternatively employed for immobilization. Immobilization on 
aldehyde agarose relies on the reaction between not protonated ε-amino groups of surface lysines and aldehyde groups on the 
support. Since alkaline conditions (pH ≥ 10) are required to ensure that the ε-amino groups are not protonated, stability studies 
of both soluble enzymes were carried out at this pH. BmGDH lost more than 50% of the initial activity after 1 hour of 
incubation at pH 10.0 both at 25 and 4 °C. The addition of stabilizing agents (glycerol or PEG600) allowed to maintain 100% 
and 70% of the initial activity after 3 hours of incubation at pH 10 [30, 31]. On the other side, KRED1-Pglu retained 100% of 
its initial activity over 3 hours at pH 10.0 under all the conditions tested (25 °C or 4 °C with 20% glycerol as additive). On 
the basis of these stability tests, immobilization of KRED1-PGlu was assayed under different conditions. The best results for 
the immobilization of KRED1-PGlu were obtained at 4 °C without additives and independently from protein loading (Table 
1, entry 1 and 3). For BmGHD, as a consequence of the stability requirements, it was necessary to add stabilizing additives to 
the immobilization mixture. The addition of 20% of glycerol allowed to retain 32% and 28% of activity upon immobilization 
at 25 °C (Table 1, entry 7 and 9) while the addition of PEG600 was not beneficial to the immobilization outcome (Table 1, 
entry 8 and 10). 
 
Table 1. Immobilization of KRED1-PGlu and BmGDH.a 
Entry Enzyme Load (mg g-1) T (°C) Additive Immobilized protein (%)b Yield (%) 
1 KRED1-PGlu 7 4 - 98 40c 
[a] Experimental conditions: pH 10.0, 3 h. [b] Determined by Bradford method. [c] Determined by comparison of the loaded and recovered activity towards 
4’-nitroacetophenone (1a) [32]. [d] Determined by comparison of the loaded and recovered activity assayed towards glucose. 
 
The stability of the free and immobilized enzymes was compared at 30°C in the presence of different concentrations of DMSO 
(Fig. S1 and S2), a water-soluble solvent often employed for solubilizing hydrophobic substrates in biocatalytic reactions. 
Immobilization remarkably improved the enzymatic stability towards DMSO: 60-65% residual activity was found for 
immobilized KRED1-Pglu after 24 hours in the presence of 5-20% DMSO, and only 4-6% of the original activity was lost in 
the case of immobilized BmGDH. It should be noted that both the free enzymes were mostly inactivated after 6 hours even at 
the lowest DMSO concentration (Fig. S1A and S2A).  
The two immobilized proteins were blended together to obtain a homogeneous agarose gel system suited for catalyzing the 
stereoselective reduction of ketones at 30° C with an efficient regeneration system for NADPH/NADP+. This system was able 
to convert 4-nitroacetophenone 1a with yields between 78-83% in the presence of DMSO ranging from 4 to 8% while lower 
yields were observed at higher co-solvent concentrations (Figure 1); 2a was always recovered with an ee > 98%. Sluggish 
reactions could be observed with free enzymes in the presence of DMSO concentrations above 4%. Compound 1a is mostly 
insoluble in water at 30 °C, while it is largely soluble in aqueous solutions with DMSO concentrations above 4%. 
 
2 KRED1-PGlu 7 25 - 97 14 c 
3 KRED1-PGlu 14 4 - 98 40 c 
4 KRED1-PGlu 14 25 - 92 12 c 
5 KRED1-PGlu 7 25 20% glycerol 99 12 c 
6 KRED1-PGlu 14 25 20% glycerol 97 9 c 
7 BmGDH 5 25 20% glycerol 92 32 d 
8 BmGDH 5 25 20% PEG600 87 5 d 
9 BmGDH 10 25 20% glycerol 90 28 d 
10 BmGDH 10 25 20% PEG600 84 5 d 
 
Fig. 1. Reduction of 1a into 2a by free and immobilized KRED1-Pglu/BmGDH in the 
presence of different concentrations of DMSO (batch reactions). 
 
The re-usability of the immobilized system was investigated in a sequence of reaction cycles performed in the presence of 5% 
DMSO, where the biocatalysts were recovered by filtration after every cycle and used for a new batch reaction. The 
immobilized biocatalysts lost 20% of the original activity after one cycle and were totally inactive after 4 reaction cycles (see 
Fig. S3).  
The reduction of 1a was then carried out with the immobilized enzymes in a continuous packed bed flow reactor. Different 
amounts of the immobilized enzymes were mixed to find the best KRED1-Pglu/BmGDH ratio (see Fig. S4). The best results 
(>97% conversion with a residence time of 180 min) were obtained using a KRED1-Pglu/BmGDH ratio of 1/25, 
corresponding to 55 mU for KRED1-Pglu (100 mU/g), and 1375 mU for BmGDH (2750 mU/g).  
The continuous flow reaction was carried out for 15 days in the presence of 5% DMSO with no significant change of the 
chemical composition of the outflow solution, which contained 97-98% of optically pure (S)-1-(4-nitrophenyl)ethanol (2a) 
(Fig. 2). Noteworthy, after 6 months of operation, the flow reactor only lost 30-32% of the original activity. The different 
operational stability shown by the immobilized system in the flow reactor and in shaken flasks may be due to the reduced 
mechanical stress under flow conditions. It should be underlined that biotransformations with immobilised enzymes are multi-
phase systems needing continuous agitation in conventional batch reactors, agitation (orbital shaking in our case) can damage 
or grind the biocatalyst to fine particles [33]. 
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Fig. 2. Continuous reduction of 1a in flow reactor. 
 
The flow reaction was also applied to the stereoselective reduction of other ketones (1b-1d). These substrates have a different 
solubility in water: compounds 1b and 1c are mostly soluble in 10% DMSO aqueous solutions, whereas ethyl secodione 1d, 
a key intermediate for the synthesis of a number of hormonal contraceptives [34, 35], is soluble only at 20% DMSO 
concentration. Flow reactions were carried out by pumping aqueous-DMSO solutions containing the substrate (3.0 mM), 
NADP+ (0.1 mM), and glucose (12.0 mM) through the packed bed reactor. The highest yield was achieved at relatively low 
residence times (Table 2). 1-Phenylpropane-1,2-dione 1b (3 mM) gave optically pure (S)-2-hydroxy-1-phenylpropan-1-one 
(Table 2, entry 1) with a total conversion in correspondence of a very low residence time (7 min); the same reaction catalysed 
by the  free enzymes in batch mode gave a total conversion of the substrate (3 mM) in 60 min. 1-Phenylbutane-1,3-dione 1c 
was reduced to (S)-3-hydroxy-1-phenylbutan-1-one 2c by the free enzymes in pure aqueous solution with a maximum yield 
of 60% (ee >98%) after 24 hours; the reduction in flow by immobilized enzymes and 10% DMSO allowed for a very high 
yield (95%) with a residence time of 120 min (Table 2, entry 2). A less pronounced improvement of the productivity was 
observed for the enantioselective reduction of the highly water-insoluble secodione 1d. In fact, the reaction of 1d with the 
free enzymes in batch gave yields up to 65% after 8 hours starting from 6.5 mM substrate concentration, under conditions 
where the substrate was largely insoluble [35]; when the bioconversion was transferred in the flow mode, it was necessary to 
use a flow stream containing lower substrate concentration (3 mM) and relatively high DMSO concentrations (20%) to have 
a homogeneous system. Under these conditions, yields of 65% were reached with a residence time of 180 min (Table 2, entry 
3). 
 
Table 2. Continuous stereoselective reduction of diketones 1b-1d (3 mM) with immobilized KRED1-Pglu/BmGDH in flow reactor.a 
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Entry Subst. DMSO 
(%) 
Residence 
time (min) 
Conversion 
day 1 (%)b 
Conversion 
day 15 (%)b 
Space time 
yield (mg d-1) 
Catalyst productivity 
(mmol U-1) 
Product 
recovered (mg)c 
1 1b 10 7 > 98 96-97 81.5 150.1 1199 
2 1c 10 120 95-96 93-94 5.0 8.4 67 
3 1d 20 180 64-65 62-63 4.4 3.8 60 
[a] Flow solutions contained [1b-d] 3.0 mM, [NADP+] 0.1 mM, [glucose] 12.0 mM in Tris HCl buffer pH 8.0 (50 mM) in the presence of different amounts 
of DMSO. [b] Determined by HPLC. [c] After purification by flash chromatography. 
 
The flow biotransformation of ketones 1b-1d was carried out in a continuous mode without significant changes of the 
composition of the outflow stream for 15 days; details about the continuous reaction in the flow reactor of the three substrates 
(residence times, conversions, stability, enantiomeric excesses, space time yields, and isolated yields) are given in Table 2. 
The stability of the biocatalysts under these conditions enabled the obtainment of millimolar amounts of the desired products 
in a 0.90 mL reactor, using the same amount of enzyme that produced only micromolar quantities in batch reactions. 
In conclusion, an immobilized system composed of a ketoreductase (KRED1-Pglu) and a glucose dehydrogenase (BmGDH) 
was successfully used to perform the continuous stereoselective reduction of ketones in a flow reactor for weeks; the prolonged 
operational stability in the flow reactor makes the set-up of the biotransformation attractive for preparative (bio)catalysis. 
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